PMDD symptoms occur in a consistent cyclical pattern, emerging in the luteal phase and remitting after the onset of menstruation. This predictable timing is one of the most important diagnostic indicators distinguishing PMDD from a generalised mood disorder.
PMDD
Premenstrual Dysphoric Disorder, known as PMDD, is a severe and clinically recognised hormonal condition characterised by profound psychological and physical symptoms that occur predictably in the luteal phase of the menstrual cycle, the week or two preceding menstruation, and resolve within a few days of the period beginning.
Overview
What Is PMDD?
Premenstrual Dysphoric Disorder, known as PMDD, is a severe and clinically recognised hormonal condition characterised by profound psychological and physical symptoms that occur predictably in the luteal phase of the menstrual cycle, the week or two preceding menstruation, and resolve within a few days of the period beginning. It is distinct from premenstrual syndrome (PMS) not merely in degree but in the nature and severity of its impact on a woman's ability to function.
PMDD is classified as a depressive disorder in the DSM-5 and is recognised by NICE and the Royal College of Obstetricians and Gynaecologists (RCOG) as a distinct clinical condition requiring targeted treatment. Yet despite this formal recognition, it remains chronically underdiagnosed. Women presenting with cyclical psychological symptoms are frequently offered antidepressants without any hormonal assessment, or are told that their symptoms are an expected part of being female, an explanation that is both clinically inaccurate and profoundly unhelpful.
At The Schoeman Clinic, PMDD is treated as what it is: a neurobiological condition with a hormonal substrate, requiring careful specialist investigation and a genuinely personalised treatment approach.
Symptoms
Symptoms of PMDD
Psychological symptoms are typically the most prominent and distressing. These include severe low mood, sometimes with feelings of hopelessness that can be significant enough to generate concerns about safety; intense anxiety and tension; marked irritability and anger that is disproportionate to circumstances; emotional dysregulation and sudden tearfulness; and a pronounced sense of being overwhelmed. Many women describe feeling like an entirely different person in the days before their period.
Cognitive symptoms include difficulty concentrating, poor memory, and a sense of mental fogginess that impairs professional and personal functioning. Sleep disruption is common, including difficulty falling or staying asleep and waking unrefreshed.
Physical symptoms accompany the psychological presentation and may include breast tenderness, bloating, joint or muscle pain, headaches, and fatigue. The physical burden of PMDD compounds the psychological symptoms and contributes to the overall impact on quality of life.
The consequences of unmanaged PMDD extend beyond the symptomatic days themselves. The anticipatory anxiety about the approaching luteal phase, and the recovery period required after particularly severe episodes, means that PMDD can affect wellbeing across the entire cycle, not only during the fortnight in which symptoms are active.
Causes
Causes and Contributing Factors
PMDD does not arise from abnormal hormone levels per se. Research consistently shows that women with PMDD do not have higher or lower levels of oestrogen or progesterone than women without the condition. The underlying mechanism is an abnormal neurological sensitivity to the normal hormonal fluctuations of the menstrual cycle, particularly the rise and fall of progesterone and its metabolite allopregnanolone, which acts on GABA receptors in the brain.
This neurobiological sensitivity appears to have a genetic component and is associated with altered serotonin signalling, disrupted HPA axis regulation, and, in some women, inflammatory processes that compound the neurological response to hormonal change.
Contributing factors that may worsen PMDD severity include nutritional deficiencies, particularly in magnesium, vitamin B6, and vitamin D; chronic stress and HPA axis dysregulation; gut dysbiosis and poor gut-brain axis function; thyroid dysfunction; and inadequate sleep. Identifying and addressing these factors is a central part of functional medicine management of PMDD.
Diagnosis
How We Diagnose PMDD
Diagnosis of PMDD is primarily clinical and requires prospective symptom tracking across at least two menstrual cycles to confirm the luteal-phase pattern of symptom onset and resolution. Your doctor takes a thorough symptom history, reviews any prior investigations or treatments, and establishes the cyclical pattern of your symptoms before developing an assessment plan.
Hormonal panel testing may include oestradiol, progesterone, LH, FSH, testosterone, SHBG, DHEA-S, thyroid function including TSH, free T3, free T4, and thyroid antibodies, cortisol rhythm, melatonin, and a comprehensive nutritional screen. Testing is conducted through The Doctors Laboratory (TDL) and interpreted alongside your full clinical presentation.
Where thyroid dysfunction, adrenal dysregulation, or other hormonal conditions are identified as contributing factors, these are assessed and treated concurrently. PMDD does not exist in isolation, and its severity is frequently compounded by other hormonal imbalances that standard assessments do not capture.
Treatment
Our Approach to PMDD Treatment
-
Hormonal Panel Testing and Bioidentical Hormone Therapy
Treatment is guided by the specific hormonal and biochemical profile identified through testing. For some women, targeted progesterone support using body-identical micronised progesterone significantly reduces the severity of luteal-phase symptoms by stabilising the hormonal fluctuation that triggers neurological sensitivity. Schoeman draws on her advanced training in bioidentical hormone therapy through WorldLink Medical and the Marion Gluck Training Academy to design a precise hormonal strategy appropriate to each individual patient.
-
Functional Medicine Investigation
We investigate the functional and nutritional factors that contribute to PMDD severity: gut health, HPA axis regulation, nutritional sufficiency, inflammatory load, and sleep quality. These are addressed through targeted interventions informed by your test results.
-
Nutritional Medicine and Targeted Supplementation
Specific nutritional deficiencies have a meaningful evidence base in PMDD, particularly magnesium, vitamin B6, calcium, and vitamin D. Supplemental protocols are tailored to your individual deficiency profile rather than applied generically. Dietary patterns that support serotonin production, reduce inflammation, and stabilise blood glucose are incorporated into treatment recommendations.
-
Lifestyle and Stress Physiology
Chronic stress is both a driver and amplifier of PMDD severity. HPA axis dysregulation affects progesterone metabolism and neurological resilience. We address stress physiology directly within your treatment plan, incorporating evidence-based approaches to cortisol regulation, sleep architecture, and nervous system support.
-
Ongoing Monitoring and Adjustment
Because PMDD fluctuates with the cycle and can change in severity over time, treatment plans are reviewed regularly. Follow-up consultations assess symptom progression alongside repeat testing, allowing your doctor to adjust the treatment strategy in response to your evolving clinical picture.
Why us
Why Choose The Schoeman Clinic for PMDD Care?
Women with PMDD frequently arrive at The Schoeman Clinic having already been prescribed antidepressants or told that their symptoms are not severe enough to warrant specialist attention. We take a fundamentally different view. PMDD is a clinically recognised condition with a neurobiological basis, and it deserves the same rigorous, personalised clinical attention as any other hormonal disorder.
Schoeman's combined training in general practice, functional medicine, and specialist hormonal medicine gives her the clinical range to assess PMDD comprehensively and to develop treatment plans that address its hormonal, nutritional, and physiological drivers rather than simply managing its most prominent symptom.
The Schoeman Clinic is CQC-registered and adheres to NICE guidelines, RCOG guidance, IFM frameworks, WorldLink Medical protocols, and GMC standards throughout all patient care.
Continue
Where to go next.
Questions
Frequently asked questions
If your question is not answered here, our patient office will take it personally.
Book a consultationPremenstrual syndrome (PMS) describes a range of physical and mood-related symptoms occurring before menstruation that, while uncomfortable, do not prevent normal functioning. PMDD is characterised by symptoms that are severe enough to significantly impair a woman's ability to work, maintain relationships, and carry out daily activities. The key distinction is the degree of functional impairment. PMDD is a clinically recognised condition with a specific diagnostic framework; PMS is not.
Cyclical pattern is central to the diagnosis of PMDD, but the timing is not always obvious without careful tracking. Symptoms typically emerge in the week or two before menstruation and improve within a few days of it starting, but individual variation exists. Prospective symptom tracking across two cycles is the most reliable way to establish whether a luteal-phase pattern is present.
SSRIs can be effective in PMDD for some women and have a recognised evidence base for luteal-phase dosing. However, they are not the only option, and for women who do not respond to them, who experience significant side effects, or who prefer a hormonal approach, targeted bioidentical hormone therapy and functional medicine interventions may offer meaningful benefit. Your doctor will discuss all appropriate options during your consultation.
Yes. The hormonal fluctuations of perimenopause frequently intensify existing PMDD or trigger PMDD-like symptoms in women who had previously manageable premenstrual symptoms. The perimenopausal transition is one of the most common times for women to present to us with worsening luteal-phase psychological symptoms, and it requires careful assessment to distinguish between PMDD, perimenopausal mood changes, and other contributing hormonal factors.
No. You may self-refer directly to The Schoeman Clinic. We recommend keeping your GP informed of any specialist private care you are receiving.
Next step
Book a PMDD
Consultation
If cyclical psychological or physical symptoms are disrupting your life and you want a thorough hormonal and functional assessment, we are here to provide it.
Clinics
96 Harley Street
London W1G 7HY
4 St Marks Place
Wimbledon, London SW19 7NP
Patient office
The Schoeman Clinic is a CQC-registered private medical clinic. All clinical content on this page has been written or reviewed by Dr Gina Schoeman MB ChB, MBA, Dip Derm, MRCGP, MBCAM, AFMCP. This page is intended for informational purposes and does not constitute individual medical advice. Please book a consultation to receive advice tailored to your specific circumstances.
